Mark Phillips
Carleton University
H-index: 37
North America-Canada
Top articles of Mark Phillips
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Understanding network meta-analysis methodology for the ophthalmologist | Mark Phillips Varun Chaudhary | 2024/5/1 | |
The ophthalmologist’s guide to evaluating the certainty of evidence using the GRADE approach | Eye | Dena Zeraatkar Tyler Pitre Mark Phillips David H Steel Charles C Wykoff | 2024/2/5 |
Anti‐vascular endothelial growth factor therapy and retinal non‐perfusion in diabetic retinopathy: A meta‐analysis of randomised trials | Keean Nanji Gurkaran S Sarohia Jim Xie Nikhil S Patil Mark Phillips | 2024/2 | |
Health economic assessments of hyaluronic acid treatments for knee osteoarthritis: A systematic review | Anil Ranawat Kaiwen Guo Mark Phillips Amy Guo Faizan Niazi | 2024/1 | |
The effect of complement C3 or C5 inhibition on geographic atrophy secondary to age-related macular degeneration: A living systematic review and meta-analysis | Anubhav Garg Keean Nanji Felicia Tai Mark Phillips Dena Zeraatkar | 2023/11/24 | |
Understanding the learning curve of carpal tunnel release with ultrasound guidance: a review | Seper Ekhtiari Mark Phillips Dalraj Dhillon Ali Shahabinezhad Mohit Bhandari | 2023/7/15 | |
What makes a good survey? | Eye | Yaping Chang Li Wang Mark R Phillips Charles C Wykoff Sunir J Garg | 2023/11 |
Patient-Reported Outcome Measure Usage in Guidelines Published by the American Academy of Ophthalmology-a Review | W Yu Caberry Keean Nanji Amin Hatamnejad Mohamed Gemae Ishraq Joarder | 2023/7/8 | |
Subthreshold Compared to Threshold Macular Photocoagulation for Diabetic Macular Edema: A Systematic Review and Meta-Analysis | Felicia Tai Keean Nanji Anubhav Garg Dena Zeraatkar Mark Phillips | 2023/10/5 | |
Noninferiority randomised trials in ophthalmology | Eye | Kevin Kim Dena Zeraatkar Tyler S Pitre Mark Phillips Charles C Wykoff | 2023/10 |
Correction: The 5 min meta-analysis: understanding how to read and interpret a forest plot | Eye | Yaping Chang Mark R Phillips Robyn H Guymer Lehana Thabane Mohit Bhandari | 2023/12 |
Interpreting results from randomized controlled trials: What measures to focus on in clinical practice | Eye | Andrea J Darzi Jason W Busse Mark Phillips Charles C Wykoff Robyn H Guymer | 2023/10 |
Serious reporting deficiencies exist in minimal important difference studies: current state and suggestions for improvement | Alonso Carrasco-Labra Tahira Devji Anila Qasim Mark Phillips Bradley C Johnston | 2022/10/1 | |
Risk of bias: why measure it, and how? | Eye | Mark R Phillips Peter Kaiser Lehana Thabane Mohit Bhandari Varun Chaudhary | 2022/2 |
Guidelines for patient management: considerations before adoption into practice | Eye | Andrea J Darzi Jason W Busse Mark R Phillips Rishi P Singh Frank G Holz | 2022/6 |
The clinician’s guide to interpreting a regression analysis | Eye | Sofia Bzovsky Mark R Phillips Robyn H Guymer Charles C Wykoff Lehana Thabane | 2022/9 |
The clinician’s guide to p values, confidence intervals, and magnitude of effects | Mark R Phillips Charles C Wykoff Lehana Thabane Mohit Bhandari Varun Chaudhary | 2022/2 | |
Cohort studies investigating the effects of exposures: key principles that impact the credibility of the results | Eye | Anna Miroshnychenko Dena Zeraatkar Mark R Phillips Sophie J Bakri Lehana Thabane | 2022/5 |
Treat‐and‐extend regimens of anti‐vascular endothelial growth factor therapy for retinal vein occlusions: a systematic review and meta‐analysis | Keean Nanji Mohammad Khan Muhammad F Khalid Jim S Xie Gurkaran S Sarohia | 2022/9 | |
New Work im New Office–Der Wandel der Arbeitswelt und dessen Auswirkungen auf den Büroalltag | Angelika Donhauser Mark Phillips Jennifer Vogt | 2022/1/4 |
